Delphia Therapeutics
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2024
- Business Model
- B2B
- Website
- delphiatx.com
- Total Funding
- $67.0M
- Last Round
- $67.0M Series AMay 2024
About
Biotech developing 'activation lethality' cancer therapeutics that overactivate oncogenes to selectively kill tumor cells.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account